A cancer cell proliferation inhibitor including at least one selected from compounds represented by Structural Formulae (1) to (8), wherein the cancer cell is at least one of a cancer cell overexpressing a wild-type epidermal growth factor receptor and a cancer cell expressing an epidermal growth factor receptor mutant vIII.
一种癌细胞增殖
抑制剂,包括至少选择以下化合物之一:结构式(1)至(8)所代表的化合物,其中癌细胞至少为过表达野生型
表皮生长因子受体的癌细胞和表达
表皮生长因子受体突变体vIII的癌细胞之一。